bibliographicCitation |
Jin Z, Wang Y, Wang J, Zhang J, Wu L, Wang Z. Long-term survival benefit of ruxolitinib in a patient with relapsed refractory chronic active Epstein–Barr virus. Annals of Hematology. 2019 Mar 04;98(8):2003–4. doi: 10.1007/s00277-019-03647-5. |